Merit Medical Gets Approval From Health Canada for Wrapsody CIE

MT Newswires Live
May 06

Merit Medical Systems (MMSI) said Tuesday that Health Canada has approved Wrapsody Cell-Impermeable Endoprosthesis that is

designed to help physicians prolong functional vascular access in hemodialysis patients.

The company said it plans to start immediate commercialization of the device in the country.

Price: 92.98, Change: -0.97, Percent Change: -1.03

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10